Epigenetics of kidney cancer and bladder cancer

Amanda M Hoffman1, Paul Cairns

  • 1Departments of Surgical Oncology & Pathology, W350, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Epigenomics
|December 1, 2011
PubMed

Insights

This study reviews epigenetic alterations, including gene promoter hypermethylation, in cancer. Understanding these changes in kidney and bladder cancers can aid in diagnosis and prognosis.

Area of Science:

  • Epigenetics
  • Molecular Oncology
  • Cancer Genomics

Background:

  • Epigenetic alterations, specifically aberrant promoter hypermethylation, are key in cancer development.
  • Classical tumor suppressor genes and other cancer-related genes are frequently affected by hypermethylation in both inherited and sporadic cancers.
  • Kidney and bladder cancers present significant clinical challenges due to high mortality and recurrence rates.

Purpose of the Study:

  • To summarize current knowledge on gene hypermethylation in cancer cells.
  • To discuss global and array-based studies of tumor cell hypermethylation.
  • To explore the translational application of gene hypermethylation for kidney and bladder cancer diagnosis and prognosis.

Main Methods:

  • Review of existing literature on gene hypermethylation, histone modifications, and RNA interference in cancer.
  • Gene-by-gene summary of hypermethylation in tumor suppressor and cancer genes.
  • Discussion of global and array-based hypermethylation studies.

Main Results:

  • Aberrant promoter hypermethylation is a significant epigenetic alteration in cancer cells.
  • Histone modifications and microRNAs (miRNAs) also play roles in kidney and bladder tumor cells.
  • Standardization of methylation scoring is crucial for accurate assessment.

Conclusions:

  • Gene hypermethylation is a critical factor in the pathogenesis of kidney and bladder cancers.
  • Translational application of gene hypermethylation can improve diagnosis and prognosis for these cancers.
  • Further research into epigenetic modifications is essential for advancing cancer management.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...